Drug-Induced Cholestasis

Acocella F, Nicolis FB, Tenconi LT. The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin bromosulphthalein and indocyanine green in man. Gastroenterology 48: 521–525, 1965 Adlercreutz H, Ikonen G. Oral contraceptives and liver damage. British Medical Journal 2: 1133, 1964 Adlercreutz H, Tenhunen R. Some aspects of the interaction between natural and synthetic female sex hormones and the liver. American Journal of Medicine 49: 630–648, 1970 Adinolfi LE, Utili R, Gaeta GB, et al. Cholestasis induced by estradiol-17β-D-glucuronide: mechanisms and prevention by sodium taurocholate. Hepatology 4: 30–37, 1984 Agrawal B, Zelkowitz L. Bone ‘flare’, hypercalemia and jaundice after tamoxifen therapy. Archives of Internal Medicine 141: 1240–1242, 1981 Alarcon-Segovia D, Fishbein E, Cetina JA, Raya RJ, Barrera E. Antigenic specificity of chlorpromazine-induced antinuclear anti-bodies. Clinical and Experimental Immunology 15: 543–548, 1973 Al-Kawas FH, Seeff LB, Berendson RA, et al. Allopurinol hepatotoxicity: report of two cases and review of the literature. Annals of Internal Medicine 95: 588–590, 1981 Ammann R, Neftel K, Hardmeier T, et al. Cephalosporin-induced cholestatic jaundice. Lancet 2: 336–337, 1982 Anderson RJ. Severe reaction associated with sulindac administration. New England Journal of Medicine 300: 735–736, 1979 Antonelli D, Koltun B, Barzilay J. Acute hepatotoxic effect of disopyramide. Chest 8: 274, 1984 Arbruzzese A, Swanson J. Jaundice after therapy with chlordiazepoxide hydrochloride. New England Journal of Medicine 273: 321–322, 1965 Arias IM. Effects of a plant acid (icterogenin) and certain anabolic steroids on the hepatic metabolism of bilirubin and sulfobromophthalein. Annals of the New York Academy of Sciences 104: 1014–1025, 1963 Arias IM. Ion transport into and out of the liver. In Kappler et al. (Eds) Mechanisms of hepatocyte injury and death; pp. 49–56, MTP Press, Lancaster, 1983 Arias IM. Mechanisms and consequences of ion transport in the liver. Progress in Liver Disease 8: 145–160, 1986 Arias IM, Gartner LM, Seifter S, et al. Prolonged neonatal unconjugated hyperbilirubinemia associated with breast feeding and steroid pregnane-3α,20βdiol, in maternal milk that inhibits glucuronide formation in vitro.Journal of Clinical Investigation 43: 2037–2047, 1964 Australian Drug Evaluation Committee. The erythromycins: a further report from the Australian drug evaluation committee. Australian Family Physician 2: 588–560, 1973 Bachman BA, Boyd WP, Brady PG. Erythromycin ethylsuccinate-induced cholestasis. American Journal of Gastroenterology 77: 397–400, 1982 Bagheri SA, Boyer JL. Peliosis hepatitis associated with analgesic anabolic steroid therapy: a severe form of hepatic injury. Annals of Internal Medicine 81: 610–618, 1974 Bakris GL, Cross PD, Hammarsten JE. Disopyramide-associated liver dysfunction. Mayo Clinic Proceedings 58: 265–267, 1983 Barr GD, Piper DW. Possible ranitidine hepatitis. Medical Journal of Australia 2: 421, 1981 Barnwell SG, Lowe PJ, Coleman R. The effects of colchicine on secretion into bile of bile salts, phospholipids, cholesterol and plasma membrane enzymes: bile salts are secreted unaccompanied by phospholipids and cholesterol. Biochemical Journal 220: 723–731, 1984 Bass BH. Jaundice associated with naproxen. Lancet 1: 998, 1974 Bassan H, Kendler J, Zimmerman HJ. Effect of ethionine and ethanol on the function of the perfused rat liver. Proceedings of the Society For Experimental Biology and Medicine 137: 852–857, 1971 Bassendine MF, Woodhouse KW, Bennett M, James OF. Dextropropoxyphene induced hepatotoxicity mimicking biliary tract disease. Gut 27: 444–449, 1986 Beale EF, Nelson RM, Bucciarelli RL, et al. Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics 65: 342–347, 1979 Beermann B, Ericsson JLE, Hellstrom K, et al. Transient cholestasis during treatment with ajmaline and chronic xanthomatous cholestasis after administration of ajmaline, methyltesterone and ethinyl estradiol: two case reports. Acta Medica Scandinavica 190: 241–250, 1971 Belt RJ, McGregor D, Haas CD, et al. Cholestatic jaundice associated with chlorozotocin. Cancer Treatment Reports 64: 1235–1239, 1980 Bena JH. Possible mild reaction to erythromycin ethylsuccinate. Journal of the Kansas Medical Society 80: 418, 1979 Bengoa JM, Hanauer SB, Sitrin MD, et al. Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease. Hepatology 5: 79–84, 1985 Benjamin SB, Ishak KG, Zimmerman HJ, et al. Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature. Hepatology 1: 255–263, 1981 Bennion LJ, Mott DM, Howard BV. Oral contraceptives raise the cholesterol saturation of bile by increasing biliary cholesterol secretion. Metabolism 29: 18–22, 1980 Berk PD, Javitt NB. Hyperbilirubinemia and cholestasis. American Journal of Medicine 64: 311–326, 1978 Billing BH, Maggiore Q, Goulis G. The action of cholecystographic contrast media and novobiocin on the hepatic transport of bilirubin, In Taylor (Ed.) The biliary system, pp. 219–226, F.A. Davis, Philadelphia, 1965 Black DD, Suttle EA, Whitington PF, et al. The effect of short-term parenteral nutrition on hepatic functioning of the human neonate: a prospective randomized study demonstrating alteration of hepatic canalicular function. Journal of Pediatrics 99: 445–449, 1981 Black M, Mitchell JR, Zimmerman HJ, et al. Isoniazid-associated hepatitis in 114 patients. Gastroenterology 69: 289–302, 1975 Black M, Scott Jr WE, Kanter R. Possible ranitidine hepatotoxicity. Annals of Internal Medicine 101: 208–210, 1984 Blackburn AM, Amiel SA, Millis RR, et al. Tamoxifen and liver damage. British Medical Journal 289: 288, 1984 Blitzer BL, Boyer JL. Cytochemical localization of Na+, K+-ATPase in the rat hepatocyte. Journal of Clinical Investigation 62: 1104–1108, 1978 Blom H, Stolk J, Schreuder HB, et al. A case of carbimazole-induced intrahepatic cholestasis: an immunemediated reaction? Archives of Internal Medicine 145: 1513–1515, 1985 Bloomer JR, Zaccaria J, Klatskin G. Inhibitory effect of scillaren and dinitrophenol on bilirubin excretion by the isolate perfused liver. Proceedings of the Society of Experimental Biology & Medicine 151: 539–542, 1976 Boelsterli UA, Rakhit G, Bialazs T. Modulation by S-adenosyl-L-methionine of hepatic (Na+,K+-ATPase), membrane fluidity, and bile flow in rats with ethinyl estradiol-induced cholestasis. Hepatology 3: 12–17, 1983 Bolton JS, Bowen JC. Biliary sclerosis associated with hepatic artery infusion of floxuridine. Surgery 99: 119–122, 1986 Borsch G, Schmidt G, Hopemann G, et al. Prajmalium bitartrate associated liver damage: report on several further cases with follow-up for two to five years. Klinische Wochenschrift 62: 998–1000, 1984 Bosio M. Cholestatic jaundice and hematuria due to hypersensitivity to cefaclor in a child. Journal of Toxicology and Clinical Toxicology 20: 79–84, 1983 Botet JF, Watson RC, Kemany N, et al. Cholangitis complicating intraarterial chemotherapy in liver metastases. Radiology 156: 335–337, 1985 Boue F, Coffin B, Delfraissy J-F. Danazol and cholestatic hepatitis. Annals of Internal Medicine 105: 139–140, 1986 Boyer JL. Mechanisms of chlorpromazine cholestasis: hypersensitivity or toxic metabolite? Gastroenterology 74: 1331–1333, 1978 Boyer JL. New concepts of mechanisms of hepatocyte bile formation. Physiological Reviews 60: 303–326, 1980 Boyer JL. Tight junctions in normal and cholestatic liver: does the paracellular pathway have functional significance? Hepatology 3: 614–617, 1983 Braun P. Hepatotoxicity of erythromycin. Journal of Infectious Disease 119: 300–306, 1969 Brienstrup H, Sgaard-Andersen J. Intra-hepatic cholestasis after griseofulvin treatment. Ugeskrift for Laeger 128: 145–146, 1966 Brogden RN, Heel RC, Speight TM, et al. Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic disease. Drugs 16: 97–114, 1978 Bromidge ES, Wells JW, Wight PA. Elevated bile acids in the plasma of laying hens fed rapeseed meal. Research of Veterinary Science 39: 378–382, 1985 Brown RA. Two cases of untoward reactions after ‘Ilosone’. British Medical Journal 2: 913–914, 1963 Bullock G, Eakins MN, Sawyer BC, et al. Studies on bile secretion with the aid of the isolated perfused liver. Inhibitory action of sporidesmin and icterogenin. Proceedings of the Royal Society of London 186: 33–356, 1974 Campbell CB, McGuffie C, Weedon AP, et al. Cholestatic liver disease associated with diphenylhydantoin therapy. Possible pathogenic importance of altered bile salt metabolism. American Journal of Digestive Diseases 22: 255–262, 1977 Capelle P, Dhumeaux D, Mora M, et al. Effect of rifampicin on liver function in man. Gut 13: 366–370, 1972 Carey MC, Hirom PC, Small DM. A study of the physical chemical interaction between biliary lipids and chlorpromazine hydrochloride. Biochemical Journal 153: 519–531, 1976 Chiprut RO, Viteri A, Jamroz C, et al. Intrahepatic cholestasis after griseofulvin administration. Gastroenterology 70: 1141–1143, 1976 Cleator IGM, Piper GW. Adverse effects of ranitidine therapy. Canadian Medical Association Journal 129: 405, 1983 Coe JE, Ishak KG, Ross MJ. Diethylstilbestrol-induced jaundice in the Chinese and Armenian hamster. Hepatology 3: 489–496, 1983 Cohen CC, Olsen MM. Pediatric total parenteral nutrition. Archives of Pathology and Laboratory Medicine 105: 152–156, 1981 Cohen L, Lewis C, Arias IM. Pregnancy, oral contraceptives, and chronic familial jaundice with predominantly conjugated hyperbilirubinemia (Dubin-Johnson Syndrome). Gastroenterology 62: 1182–1190, 1972 Colucci CF, Lo Cicero M. Fatal hepatic necrosis following therapy with trimethoprim-sulphamethoxazole mixture. Policlinico 81: 150–161, 1974 Combes B, Shibata H, Adams R, et al. Alterations in sulfobromophthalein sodium-removal mechanism from blood during normal pregnancy. Journal of Clinical Investigation 42: 1431–1442, 1963 Combes B, Shore GM, Cunningham FF, et al. Serum gamma-glutamyl-transpeptidase activity in viral hepatitis: suppression in pregnancy and by birth control pills. Gastroenterology 72: 271–272, 1977 Conradi SE, Olanoff LS, Dawson Jr WT. Fatality due to paraquat intoxication: confirmation by post-mortem tissue analysis. American Journal of Clinical Pathology 80: 771–776, 1983 Corley Jr CC, Lessne PQ, Karseb WE. Azathioprine therapy of auto immune diseases. American Journal of Medicine 41: 404–412, 1966 Coto H, Actowan WR, Pierce EH, et al. Intrahepatic cholestasis due to trimethoprim-sulfamethoxazole. Southern Medical Journal 74: 897–898, 1981 Crane GE. A review of clinical literature on haloperidol. International Journal of Neuropsychiatry 3 (Suppl.): S111–S123, 1967 Cunningham ML. Acute hepatic necrosis following treatment with amitryptyline and diazepam. British Journal of Psychiatry 111: 1107–1109, 1965 Cuthbert MF. Adverse reactions to non-steroidal anti-rheumatic drugs. Current Medical Research and Opinion 2: 600–610, 1974 Dahms BB, Halpin TC. Serial liver biopsies in parenteral nutrition-associated cholestasis of early infancy. Gastroenterology 81: 136–144, 1981 Daikos GK, Kosmidis JC. Propoxyphene jaundice. Journal of the American Medical Association 232: 835, 1975 Davis M, Eddleston AL, Williams R. Hypersensitivity and jaundice due to azathioprine. Postgrad Med 56: 274–275, 1980 Davis RA, Kern F, Showalter R, et al. Alterations of hepatic Na+-K+-ATPase and bile flow by estrogen: effects on liver surface membrane lipid structure and function. Proceedings of the National Academy of Sciences 75: 4130–4134, 1978 Dayan AD, Lewis PD. Idoxuridine and jaundice. Lancet 2: 1073, 1969 de Lamirande E, Tuchweber B, Plaa GL. Hepatocellular alteration as a possible cause of manganese-bilirubin-induced cholestasis. Biochemical Pharmacology 30: 2305–2312, 1981 Del Arbol LR, Moreira V, Horeno A, et al. Bridging hepatic necrosis associated with cimetidine. American Journal of Gastroenterology 74: 267–269, 1980 Denk H, Schenkman JB, Bacchin PG, et al. Mechanism of cholestasis. II. Interaction of synthetic detergents with the microsomal cytochrome P-450 dependent biotransformation system, invitro: a comparison between the effects of detergents, the effects of bile acids, and the findings in bile duct ligated rats. Experimental Molecular Pathology 14: 263–276, 1971 dePinho RA, Goldberg CS, Lefkowitch JH. Azathioprine and the liver: evidence favoring idiosyncratic, mixed cholestatic-hepatocellular injury in humans. Gastroenterology 86: 162–165, 1984 Despopoulus A. Hepatic and renal excretory metabolism of bile salts: a background for understanding steroid-induced cholestasis. Journal of Pharmaceutical and Experimental Therapeutics 176: 273–283, 1971 Devogelaer JP, Huaux JP, Coche E, et al. A case of cholestatic hepatitis associated with D-penicillamine therapy for rheumatoid arthritis. International Journal of Clinical Pharmacology & Research 5: 35–38, 1985 De Vos R, Desmet V. Morphology of liver cell tight junctions in ethinyl estradiol induced cholestasis. Pathology Research Practice 171: 381–388, 1981 Dhand AK, LaBreque DR, Metzger J. Sulindac (Clinoril) hepatitis. Gastroenterology 80: 585–586, 1981 Diehl AM, Latham P, Boitnott JK, et al. Cholestatic hepatitis from erythromycin ethylsuccinate: report of 2 cases. American Journal of Medicine 76: 931–934, 1984 Dincsoy HP, Saelinger DA. Haloperidol-induced chronic cholestatic liver disease. Gastroenterology 83: 694–700, 1982 Dorvil MP, Yousef IM, Tuchweber B. Taurine prevents cholestasis induced by lithocholate acid sulfate in guinea pigs. American Journal of Clinical Nutrition 37: 221–232, 1983 Drinkard JP, Stanley TM, Dornteld L, et al. Azathioprine and prednisone in the treatment of adults with lupus nephritis. Medicine 49: 411–432, 1970 Dubin M, Maurice M, Feldman G, et al. Influence of colchicine and phalloidin on bile secretion and hepatic ultrastructure in the rat. Gastroenterology 79: 646–654, 1980 Dujovne CA. Liver cell culture toxicity and surfactant potency of erythromycin derivatives. Toxicology and Applied Pharmacology 32: 11–20, 1975 Dujovne CA, Chan CH, Zimmerman HJ. Sulfonamide hepatic injury; review of the literature and report of a case due to sulfamethoxazole. New England Journal of Medicine 277: 785–788, 1967 Dujovne CA, Levy R, Zimmerman HJ. Hepatotoxicity of phenothiazines in vitroas measured by loss of aminotransferases to surrounding media. Proceedings of the Society of Experimental Biology and Medicine 128: 561–565, 1968 Dujovne CA, Pitterman A, Vincek WE, et al. Enterohepatic circulation of sulindac and metabolites. Clinical Pharmacology and Therapeutics 33: 172–177, 1983 Dujovne CA, Shoeman DW, Lasagna L. Experimental basis for the different hepatotoxicity of erythromycin preparations in man. Journal of Laboratory and Clinical Medicine 79: 832–844, 1972 Dujovne CA, Zimmerman HJ. Cytotoxicity of phenothiazines on Chang liver cells as measured by enzyme leakage. Proceedings of the Society of Experimental Biology and Medicine 131: 583–587, 1968 Duthie A, et al. Fatal cholestatic jaundice in elderly patients taking benoxaprofen. British Medical Journal 285: 62, 1982 Ebert MH, Shader RI. Hepatic effects. In Shader & DiMascio (Eds) Psychotropic drug side effects: clinical and theoretical perspectives, pp. 175–197, Williams and Wilkins Company, Baltimore, 1970 Elias E, Boyer JL. Chlorpromazine and its metabolites alter polymerization and gelation of actin. Science 206: 1404–1406, 1979 Elias E, Iobal S, Knutton S, et al. Increased tight junction permeability: a possible mechanism of oestrogen cholestasis. European Journal of Clinical Investigation 13: 383–390, 1983 Enat R, Pollack S, Ben-Arieh Y, et al. Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing and rechallenge with hepatotoxic drugs. British Medical Journal 280: 982–983, 1980 Erlinger S. Bile secretion and multiplicity of hepatic excretory mechanisms. Biologie & Gastro-enterologie (Paris) 2: 105–112, 1971 Erlinger S. Hepatocyte bile secretion: current views and controversies. Hepatology 1: 352–359, 1981 Erlinger S. What is cholestasis in 1985. Journal of Hepatology 1: 687–693, 1985 Espiritu CR, Alalu J, Glueckaf LG, et al: Allopurinol-induced granulomatous hepatitis. American Journal of Digestive Diseases 21: 804–805, 1976 Fagan EA, Walford N, Hodgson HJF. Sulindac hepatotoxicity. Gut 24: 1199, 1983 Fang MH, Ginsberg AL, Dobbins III WO. Cholestatic jaundice associated with flurazepam hydrochloride. Annals of Internal Medicine 89: 363–364, 1978 Farmer GD, Hoffman II HN, Shorter RG, et al. Intrahepatic cholestasis associated with the ingestion of erythromycin estolate (Ilosone). Gastroenterology 45: 157–160, 1963 Favreau M, Tannenbaum H, Lough J. Hepatotoxicity associated with gold therapy. Annals of Internal Medicine 87: 717–719, 1977 Firth H, Wilcock GK, Esiri M, et al. Side effects of benoxaprofen. British Medical Journal 284: 1784, 1982 Fisher BM, McArthur JD. Side effects of benoxaprofen. British Medical Journal 284: 1783, 1982 Forker BL. The effect of estrogens on bile formation in the rat. Journal of Clinical Investigation 48: 654–667, 1969 Fors B, Nilsson F. Hepatitis probably induced by diazepam medication. Lärkartidningen 65: 4628–4631, 1968 Fouin-Fortunet H, Quernec LL, Erlinger S, et al. Hepatic alterations during total parenteral nutrition in patients with inflammatory bowel disease: a possible consequence of lithocholate toxicity. Gastroenterology 82: 932–937, 1982 Freedman MR, Holzbach TT, Ferguson DR. Pruritus in cholestasis: no direct causative role for bile acid retention. American Journal of Medicine 70: 1011–1061, 1981 Freis ED, Mater DA. Intrahepatic obstructive jaundice following mapharsen, with development of a sprue-like syndrome. Journal of the American Medical Association 126: 892–894, 1944 Funck-Brentano C, Pessayre D, Benhamou JP. Hepatitis caused by various derivatives of erythromycin. Gastroenterology & Clinical Biology 7: 362–369, 1983 Gallagher TF, Mueller MN, Kappas A. Estrogen pharmacology. IV. Studies on the structural basis for estrogen-induced impairment of liver function. Medicine 45: 471–479, 1966 Gallanosa AG, Spyker DA. Sulindac hepatotoxicity: a case report and review. Clinical Toxicology 23: 205–238, 1985 George CB, Mansour RP, Redmond II J, et al. Hepatic dysfunction and jaundice following-dose cytosine arabinoside. Cancer 54: 2360–2362, 1984 Gerber SB, Miller KB. Cholestatic jaundice and aminoglutethimide. Annals of Internal Medicine 97: 138, 1982 Ghishan FK. Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis. Clinical Pediatrics 22: 212–214, 1983 Ghishan FK, LeBrecque DR, Younoszai K. Intrahepatic cholestasis after gold therapy in juvenile rheumatoid arthritis. Journal of Pediatrics 93: 1042–1043, 1978 Gimmon Z, Kelley RE, Simko V, et al. Total parenteral nutrition solution increases bile lithogenicity in the rat. Journal of Surgical Research 32: 256–263, 1982 Giroux Y, Moreau M, Kass TG. Cholestatic jaundice caused by sulindac. Canadian Journal of Surgery 25: 334–335, 1982 Goette DK. Dapsone-induced hepatic changes. Archives of Dermatology 113: 1616–1617, 1977 Goetzee AE, Richards TG, Tindall VR. Experimental changes in liver function induced by probenecid. Clinical Science 19: 63–78, 1960 Goldfarb S, Singer K, Popper H. Experimental cholangitis due to alpha-naphthyl-isothiocyanate (ANIT). American Journal of Pathology 40: 685–698, 1962 Goldstein LI, Ishak KG, Burns W. Hepatic injury associated with nitrofurantoin therapy. American Journal of Digestive Diseases 19: 987–998, 1974 Goldstein LI, Granoff M, Waisman J. Hepatic injury due to oxacillin administration. American Journal of Gastroenterology 70: 171–174, 1978 Goudie BM, Birnie GF, Watkinson G, et al. Jaundice associated with the use of benoxaprofen. Lancet 1: 959, 1982 Graham MF, Tavil AS, Halpin TC, et al. Inhibition of bile flow in the isolated perfused rat liver by a synthetic parenteral amino acid mixture: associated net amino acid fluxes. Hepatology 4: 69–73, 1984 Greaves MW, Dawber R. Azathioprine in psoriasis. British Medical Journal 2: 237–238, 1970 Greenlaw CW, Henrietta GC, Stolley SH. Hepatotoxicity possibly associated with erythromycin ethylsuccinate. Drug Intelligence & Clinical Pharmacy 13: 236–238, 1979 Gregory DH, Zaki GF, Sarosis GA, et al. Chronic cholestasis following prolonged tolbutamide administration. Archives of Pathology 84: 194–201, 1967 Gregory DS, Vlahcevic ZR, Prughl MF, et al. Mechanism of secretion of biliary lipids: role of a microtubular system in hepatocellular transport of biliary lipids in the rat. Gastroenterology 74: 93–100, 1978 Griffin AJ. Cholestatic hepatitis induced by gold. Rheumatology Rehabilitation 18: 174–176, 1979 Grosser V, Robenek H, Rassat J, et al. Ultrastructural study of cholestasis induced by long-term treatment with estradiol valerate. II. Gap-junction analysis. Virchows Archiv B. Cell Pathology (Berlin) 40: 365–378, 1982 Guarascio P, D’Amato C, Sette P. Liver damage from verapamil. British Medical Journal 288: 362–363, 1984 Gulliford M, MacKay AD, Prowse K. Cholestatic jaundice caused by ethambutol. British Medical Journal 292: 866, 1986 Gumucio J, Accationo L, Macho AM, et al. Effect of phenobarbital on the ethinyl estradiol induced cholestasis in the rat. Gastroenterology 65: 651–657, 1973 Gumucio J, Miller DL. Functional implications of liver cell heterogeneity. Gastroenterology 80: 639–645, 1981 Halsey JP, Cardoe N. Benoxaprofen: side effects profile in 300 patients. British Medical Journal 284: 1365–1368, 1982 Hammaker L, Schmid R. Interference with bile pigment uptake in the liver. Gastroenterology 53: 31–37, 1967 Hanger Jr FM, Gutman AB. Post-arsphenamine jaundice. Journal of the American Medical Association 115: 263–271, 1940 Hare DL, Horowitz JD. Verapamil hepatotoxicity: a hypersensitivity reaction. American Heart Journal 11: 610–611, 1986 Hargreaves T, Holton JB. Jaundice of the newborn due to novobiocin. Lancet 1: 829–840, 1962 Hargreaves T, Howell M. Phenindione jaundice. British Heart Journal 27: 932–936, 1965 Harney J, Glasberg MR. Myopathy and hypersensitivity to phenytoin. Neurology 33: 790–791, 1983 Hartley RA, Boitnott JK, Iber FL. The liver and oral contraceptives. Johns Hopkins Medical Journal 124: 112–118, 1969 Hartmann FL, Singer AG. Intrahepatic obstructive jaundice due to neoarsphenamine. Archives of Dermatology & Syphilis 53: 620–624, 1946 Haubrich WS, Sancetta SM. Spontaneous recovery from hepatobiliary disease with xanthomatosis. Gastoenterology 26: 658–665, 1954 Havens Jr WP. Cholestatic jaundice in patients treated with erythromycin estolate. Journal of the American Medical Association 180: 30–32, 1962 Heikel T, Knight BC, Rimington C, et al. The effect of icterogenin on bile flow and the excretion of bilirubin, phylloerythrin coproporphyrin, alkaline phosphatase and bromosulfalein. Proceedings of the Royal Society of London B 153: 47–49, 1960 Hiesse E, Cantarovich M, Santelli C, et al. Ranitidine hepatotoxicity in renal transplant patient. Lancet 1: 1280, 1985 Hindson C, Dagmond T, Diffey B, et al. Side effects of benoxaprofen. British Medical Journal 284: 1368–1369, 1982 Hohn D, Melnick J, Stagg R, Altman D, Friedman M. Biliary sclerosis in patients receiving hepatic arterial infusion of floxuridine. Journal of Clinical Oncology 1: 98–102, 1985 Hollister LE. Allergy to chlorpromazine manifested by jaundice. American Journal of Medicine 23: 870–879, 1957 Holzbach RT, Sanders JH. Recurrent intrahepatic cholestasis of pregnancy: observations on pathogenesis. Journal of the American Medical Association 193: 542–554, 1965 Horak J, Mertil L, Hrabal P. Severe liver injuries due to sulfamethoxazole-trimethoprim and sulfamethoxydiazine. Hepatogastroenterology 31: 199–200, 1984 Horst DA, Grace ND, LeCompte PM. Prolonged cholestasis and progressive hepatic fibrosis following imipramine therapy. Gastroenterology 80: 550–554, 1980 Howrie DL, Gartner Jr JC. Gold-induced hepatotoxicity: case report and review of the literature. Journal of Rheumatology 9: 727–729, 1982 Hughes CA, Talbot IC, Ducker DA, et al. Total parenteral nutrition in infancy: effect on the liver and suggested pathogenesis. Gut 24: 241–248, 1983 Hurault de Ligny B, Marist A, Kessler RS, et al. Hepatite au cours d’un polytherapie associant le captopril. Therapie 37: 698–700, 1982 Hurt VP, Wegmann T. Protrahierter Largacfilikterus mit Ubergang in primare biliare Zirrhose. Acta Hepato-Splenologica 8: 87–95, 1961 Husebye KO. Jaundice with persisting pericholangiolitic inflammation in a patient treated with chlorothiazide. American Journal of Digestive Diseases 9: 439–446, 1964 Indacochea-Redmond N, Plaa GL. Functional effects of L-naphthylisothiocyanate in various species. Toxicology & Applied Rheumatology 19: 71–80, 1971 Inman WH, Rawson NS. Erythromycin estolate and jaundice. British Medical Journal 286: 1954–1955, 1983 Ishak KG, Irey NS. Hepatic injury associated with the phenothiazines: clinical pathologic and follow-up study of 36 patients. Archives of Pathology 93: 283–304, 1972 Jacknowitz AI, Walker BK. Agranulocytosis and hepatitis as a result of Mexican drug therapy. Drug Intelligence & Clinical Pharmacy 18: 66–68, 1984 Jaeger A, Porte A, Saunder P, et al. Hepatitis secondary to a gold salt overdose. Gastroenterology & Clinical Biology 8: 660–661, 1984 Jaeschke H, Krell H, Pfaff E. No increase of biliary permeability in ethinylestradiol-treated rats. Gastroenterology 85: 808–814, 1983 Janssen PAJ, Cauwenbergh G, Symoens J. Hepatic reactions during ketoconazole treatment: a one year up date. Janssen Pharmaceutica, Beerse, 1983 Javitt NB, Arias IM. Intrahepatic cholestasis: a functional approach to pathogenesis. Gastroenterology 53: 171–175, 1967 Javitt NB, Emernan S. Effect of sodium taurolithocholate on bile flow and bile acid excretion. Journal of Clinical Investigation 47: 1002–1014, 1968 Job-Deslandre C, Delrieu F, Rondier J, et al. Hepatite cholestatique et anticorps anti-DNA induit par la d-penicillamine. Nouvelle Presse Medicale 11: 2356–2357, 1982 Johnson DA, Cattau EL, Kuritsky JN, et al. Liver involvement in the sulfone syndrome. Archives of Internal Medicine 146: 875–877, 1986 Jung W, Gebhardt R, Robenek H. Primary culture of rat hepatocytes as a model system of canalicular development, biliary secretion, and intrahepatic cholestasis. V. Disturbance of the cellular membrane and bile canalicular ultrastructure induced by chlorpromazine. Virchows Archiv B. Cellular Pathology 49: 349–363, 1985 Kakis G, Yousef IM. Pathogenesis of lithocholate- and taurolithocholate-induced intrahepatic cholestasis in rats. Gastroenterology 75: 595–607, 1978 Kako M, Toda G, Torii M, et al. Electron microscopy studies of biliary obstruction of the rat. Gastroenterology Japan 15: 600–605, 1980 Kaul A, Reddy JC, Fagman E. Hepatitis associated with use of sulindac in a child. Journal of Pediatrics 99: 650–651, 1981 Keeffe EB, Blankenship NM, Scharschmidt BF. Alteration of rat liver plasma membrane fluidity and ATPase activity by chlorpromazine hydrochloride and its metabolites. Gastroenterology 79: 222–231, 1980 Keeffe EB, Reis TC, Berland JE. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate. Digestive Disease and Science 27: 701–704, 1982 Keeffe EB, Scharschmidt BF, Blankenship NM, Ockner RK. Studies of relationships among bile flow, liver plasma membrane NaK-ATPase, and membrane microviscosity in the rat. Journal of Clinical Investigation 64: 1590–1598, 1979 Kemeny MM, Battifora H, Blayney DW, et al. Sclerosing cholangitis after continuous hepatic artery infusion of FuDr. Annals of Surgery 202: 176–181, 1985 Kendler J, Bowry S, Seeff LB, Zimmerman HJ. Effect of chlorpromazine on the function of the perfused isolated liver. Biochemical Pharmacology 20: 2439–2445, 1971 Kenwright S, Levi AJ. Sites of competition in the selective uptake of rifamycin-SV, flavaspidic acid, bilirubin and bromosulphthalein. Gut 15: 220–226, 1974 Kern Jr F, Erfling W, Simon FR, et al. Effects of estrogens on the liver. Gastroenterology 75: 512–522, 1978 Klaassen CD, Watkins JB. Mechanisms of bile formation hepatic uptake, and biliary excretion. Pharmacological Reviews 36: 1–67, 1984 Klatskin G. Toxic and drug induced hepatitis. In Schiff (Eds) Diseases of the liver, 4th ed., p. 640, J.B. Lippincott Co, Philadelphia, 1975 Klein NC, Magida MD. Propoxyphen (Darvon) hepatotoxicity. American Journal of Digestive Diseases 15: 467–469, 1971 Kleinman MS, Presberg JE. Cholestatic hepatitis after dicloxacillin-sodium therapy. Journal of Clinical Gastroenterology 8: 77–78, 1986 Kleinman Y, Levij IS, Shotan A, et al. Prajmalium bitartrate hepatitis: report of three cases and review of the literature. Italian Journal of Gastroenterology 15: 33–36, 1983 Klerman GL, Cole JO. Clinical pharmacology of imipramine and related anti-depressant compounds. Pharmacology Review 17: 101–141, 1965 Klintmalm GBF, Iwatzuki S, Starzl TE. Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation 32: 488–489, 1981 Kohn NN, Myerson RM. Xanthomatous biliary cirrhosis following chlorpromazine. American Journal of Medicine 31: 665–670, 1961 Kontturi M, Sotaniemi E, Ahlquist J. Liver damage and estrogen therapy of prostatic cancer: case report. Scandinavian Journal of Urology and Nephrology 6: 289–294, 1972 Konz K-H, Berg PA, Seipel L. Cholestase nach antiarrhythimischer therapie mit Propafenon. Deutsche Medizine Wochenschrift 109: 1525–1527, 1984 Kopelman H, Scheuer P, Williams R. The liver lesion in Epping jaundice. Quarterly Journal of Medicine 35: 553–564, 1966 Kornreich H, Malouf NN, Hanson V. Acute hepatic dysfunction in juvenile rheumatoid arthritis. Journal of Pediatrics 79: 27–35, 1971 Kossow AS. Hepatic injury complicating sulfa therapy: case report. Military Medicine 149: 80–81, 1984 Kratzsch K-H, Buttner W, Reinhardt G. Intrahepatische Cholestase nach Chlordiazepoxid. Beitrag zur Differentialdiagnose des Arzneimittelelikterus Zeitschrift für die Gesamte Innere Medizin und Ihre Grenzgebiete 27: 408–411, 1972 Krell H, Hoke H, Pfaff E. Development of intrahepatic cholestasis by α-naphthlisothiocyanate in rats. Gastroenterology 82: 507–514, 1982 Krevsky B, Levine GM. Hepatic complications of TPN. Nutritional Support Services 3: 11–14, 1983 Kuzell WC, Schaffarzick RW, Naughler WE, et al. Phenylbutazone: further clinical evaluation. Archives of Internal Medicine 92: 646–661, 1953 Labadie H, Beauground M, Trinchet JC, et al. Hepatites a l’ajmaline: 4 cas et revue de literature. Medicin et Chirurgie Digestives 12: 181–187, 1983 Larrey D, Pessayre D, Duhamel G, et al. Prolonged cholestasis after ajmaline-induced acute hepatitis. Journal of Hepatology 2: 81–87, 1986 Lauritsen K, Havelund T, Raskin-Madsen J, et al. Ranitidine and hepatotoxicity. Lancet 2: 1471, 1984 Laudano OM. Study of the effect of rifampicin on the liver. Tijdschrift voor Gastroenterologie 16: 283–294, 1973 Law IP, Knight H. Jaundice associated with naproxen. New England Journal of Medicine 295: 1201, 1976 Layden TJ, Elias E, Boyer JL. Bile formation in the rat: the role of the paracellular shunt pathway. Journal of Clinical Investigation 62: 1375–1385, 1978 Lefkowitch JH. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and ‘cholangitis lenta’. Human Pathology 13: 19–24, 1982 Lefkowitch JH, Martin EC: Primary sclerosing cholangitis. Progress in Liver Disease 8: 557–580, 1986 LeMarchandy, Assimacopoulos-Jeannet F. Evidence for a role of the microtubular system in the secretion of newly synthesized albumin and other protein by the liver. Journal of Clinical Investigation 53: 1512–1517, 1974 Lennon HD. Relative effects of 17-d-alkylated anabolic steroids on sulfobromophthalein (BSP) retention in rabbits. Journal of Pharmacology & Experimental Therapeutics 15: 143–150, 1966 Lewis D, Madhok R, Capell H. Liver dysfunction associated with gold therapy for rheumatoid arthritis. Journal of Rheumatology 11: 395–396, 1984 Lewis JH. Hepatotoxicity of non-steroidal anti-flammatory drugs. Clinical Pharmacy 3: 128–138, 1984 Lewis JH, Zimmerman HJ, Benson GD, Ishak KG. Hepatic injury associated with ketoconazole therapy: analysis of 33 cases. Gastroenterology 86: 503–513, 1984 Lewis RG. Chlorpromazine sensitivity simulating the acute abdomen. Medical Journal of Australia 1: 37, 1963 Lidsky MD, Sharp JF. Jaundice with the use of 4-hydroxyprazolo pyrimidine. Arthritis and Rheumatism 10: 294, 1967 Lilly JR, Hitch DJ, Javitt NB. Cimetidine cholestatic jaundice in children. Journal of Surgical Research 24: 384–387, 1978 Lima MA. Ranitidine and cimetidine. Annals of Internal Medicine 100: 160–161, 1984 Lindern H, Weber D, Kloppel G. Prajmaliumbitartrat-induzierte Leberschaden. Deutsche Medizinische Wochenschrift 101: 1986–1990, 1976 Lo K-J, Eastwood IR, Edelman S. Cholestatic jaundice associated with chlordiazepoxide hydrochloride (Librium) therapy: report of a case and review of the literature. American Journal of Digestive Diseases 12: 845–849, 1967 Lorenzini I, Jezequel AM, Orlandi F. Cimetidine-induced hepatitis. Digestive Disease and Science 26: 275–280, 1981 MacSween RNM. Intrahepatic cholestasis associated with benoxaprofen therapy: pathological aspects. In Ishak (Ed.) Hepatopathology, pp. 225–229, 36th annual post-graduate course of the American Association for the Study of Liver Diseases November 3–4, 1985 Marquardt GH, Fisher CI, Levy P, et al. Effect of anabolic steroids on liver function tests and creatine excretion. Journal of the American Medical Association 175: 851–853, 1961 Matloff DS, Kaplan MM, Neer RM, et al. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D 3 treatment. Gastroenterology 83: 97–102, 1982 McGill DB, Motto JP. An industrial outbreak of toxic hepatitis due to ethylenediamine. New England Journal of Medicine 291: 278–282, 1974 McLean MR, Rees KR. Hyperplasia of bile ducts induced by α-naphthylisothiocyanate colon experimental biliary cirrhosis free from biliary obstruction. Journal of Pathology & Bacteria 76: 175–188, 1958 Meier PJ, St Meier-Abt A, Barrett C, et al. Mechanisms of taurocholate transport in canalicular and basolateral rat liver plasma membrane vesicles: evidence for an electrogenic canalicular organic ion carrier. Journal of Biological Chemistry 259: 10614–10622, 1984 Menard DB, Gisselbrecht C, Marty M, et al. Antineoplastic agents and the liver. Gastroenterology 78: 142–164, 1980 Metreau JM, Dhumeaux D, Berthelot P. Oral contraceptives and the liver. Digestion 7: 318–335, 1972 Meyers M, Slikker W, Pascoe G, et al. Characterization of cholestasis induced by estradiol 17β-D-glucuronide in the rat. Journal of Pharmacology & Experimental Therapeutics 214: 87–93, 1980 Meyers M, Slikker W, Pascoe G, et al. Steroid D-ring glucuronides: characterization of a new class of cholestatic agents in the rat. Journal of Pharmacology & Experimental Therapeutics 218: 63–73, 1981 Miguet JP, Vuitton D, Allemand H, et al. Une epidemic d’icteres due a l’association troleandomycine-contraceptifs oraux. Gastroenterologie Clinique Biologique 4: 420–424, 1980 Miner Jr PB, Sneller M, Crawford SS: Spironolactone and canrenone-induced changes in hepatic (Na+-K+)-ATPase activity, surface membrane cholesterol and phospholipid, and fluorescence polarization in the rat. Hepatology 3: 481–488, 1983 Mizoguchi Y, Ohnishi F, Monna T, et al. Studies on intrahepatic cholestasis induced in the rat by culture supernatant of activated lympocytes. Hepatogastroenterology 28: 147–150, 1981 Mullick FG, Ishak KG. Hepatic injury associated with diphenylhydantoin therapy: a clinical pathologic study of 20 cases. American Journal of Clinical Pathology 74: 442–452, 1980 Mullick FG, Ishak KG, Mahabir R, et al. Hepatic injury associated with paraquat toxicity in humans. Liver 1: 209–221, 1981 Multz CV. Cholestatic hepatitis caused by penicillamine. Journal of the American Medical Association 246: 630–634, 1981 Myers JD, Olson RE, Lewis JH, et al. Xanthomatous biliary cirrhosis following chlorpromazine with observations indicating overproduction of cholesterol, hypoprothrombinemia and the development of portal hypertension. Transactions of the Association of American Physicians 70: 243–261, 1957 Nair SS, Kaplan JM, Levine LH, Geraci K. Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis. Annals of Internal Medicine 42: 511–512, 1980 Nervi FO, Del Pozo R, Covarrubias CF, et al. The effect of progesterone on the regulatory mechanism of biliary cholesterol secretion in the rat. Hepatology 3: 360–367, 1983 Nolan JP. Endotoxin, reticuloendothelial function, and liver injury. Hepatology 1: 458–465, 1981 Oda M, Phillips MJ. Bile canalicular membrane pathology in cytochalasin B induced cholestasis. Laboratory Investigation 37: 350–356, 1977 Oelberg DG, Lester R. Cellular mechanisms of cholestasis. Annual Review of Medicine 37: 297–317, 1986 Ohsawa T, Ohtsubo M. Hepatitis associated with allopurinol. Drug Intelligence & Clinical Pharmacy 19: 431–433, 1985 Okanoue T, Kondo I, Ihrig TJ, et al. Effect of ethanol and chlorpromazine on transhepatic transport and biliary secretion of horseradish peroxidase. Hepatology 4: 253–260, 1984 Orlandi F, Jezequel AM. Pathogenesis of the cholestasis induced by C-17 alkylated steroids: ultrastructural and functional changes of the liver cells during the treatment. Revue Internationale d’Hepatologie 16: 331–333, 1966 Ottenberg R, Spiegel R. The present status of nonobstructive jaundice due to infectious and chemical agents: causative agents, pathogenesis, interrelationships, clinical characteristics. Medicine 22: 27–71, 1943 Paliard P, Vitrey D, Fournier G, et al. Perhexiline maleate-induced hepatitis. Digestion 17: 419–427, 1978 Pariente EA, Pessayre D, Bentata-Pessayre M, et al. Hepatitis due to ajmaline: report of 4 cases and review of the literature. Gastroenterologie Clinique et Biologique 4: 240–245, 1980 Park GD, Spector R, Headstream T, et al. Serious adverse reactions associated with sulindac. Archives of Internal Medicine 142: 1292–1294, 1982 Parker WA. Captopril-induced cholestatic jaundice. Drug Intelligence and Clinical Pharmacology 18: 234–235, 1984 Patel J, Schneider R. Hepatotoxic reaction to erythromycin ethyl succinate. Southern Medical Journal 77: 1343–1344, 1984 Paumgartner G, Reichen J, von Bergmann K, et al. Elaboration of hepatocytic bile. Bulletin of the New York Academy of Medicine 51: 455–471, 1975 Pearson K, Zimmerman HJ. Danazol and liver damage. Lancet 1: 645–646, 1980 Perkins J. Phenindione sensitivity. Lancet 1: 127–130, 1962 Perrault DJ, Demovitch E. Aminoglutethimide and cholestasis. Annals of Internal Medicine 100: 160, 1984 Pessayre D, Feldmann G, Degott C, et al. Gold salt-induced cholestasis. Digestion 19: 56–64, 1979 Peters ND, Ejstrup L. Penicillamin-induceret leverpåvirkning ved arthritis rheumatoides: en oversigt illustreret med en suggehistorie. Ugeskrift for Laeger 144: 1924–1927, 1982 Phillips MJ, Oda M, Mak E, et al. Microfilament dysfunction as a possible cause of intrahepatic cholestasis. Gastroenterology 69: 48–58, 1975 Phillips MJ, Oda M, Fumatsu K. Evidence for microfilament involvement in norethandrolone-induced intrahepatic cholestasis. American Journal of Pathology 93: 729–739, 1978 Phillips MJ, Oshio C, Miyairi M, et al. Intrahepatic cholestasis as a canalicular motility disorder. Evidence using cytochalasin. Laboratory Investigation 48: 205–211, 1983 Phillips MJ, Poucell S, Oda M. Biology of disease: mechanisms of cholestasis. Laboratory Investigation 54: 593–608, 1986 Pickering D. Hepatic necrosis after chlordiazepoxide therapy. New England Journal of Medicine 274: 1449, 1966 Pien EH, Zeman RK, Benjamin SB, et al. Iatrogenic sclerosing cholangitis following hepatic arterial chemotherapy infusion. Radiology 156: 329–330, 1985 Pizzuto J, Aviles A, Ramos E, et al. Cytosine arabinoside induced liver damage: histopathologic demonstration. Medical and Pediatric Oncology 11: 287–290, 1983 Plaa GL, Priestly BG. Intrahepatic cholestasis induced by drugs and chemicals. Pharmacological Reviews 28: 207–273, 1977 Popper H. Cholestasis: the future of a past and present riddle. Hepatology 1: 187–191, 1981 Popper H, Schaffner F. Pathophysiology of cholestasis. Human Pathology 1: 1–24, 1970 Popper H, Schaffner F. Cholestasis. In Berk et al. (Eds) Bockus Gastroenterology, 4th ed., Vol. 5, pp. 2697–2731, WB Saunders Company, Philadelphia, 1985 Popper H, Schaffner F, Denk H. Molecular pathology of cholestasis. In Taylor (Ed.) The hepatobiliary system: fundamental and pathological mechanisms, pp. 605–625, Plenum, New York 1975 Portman OW, Alexander M, Cornelius CE, et al. The effects of nutrition on unconjugated plasma bilirubin concentration in squirrels monkeys. Hepatology 4: 454–460, 1984 Powell-Jackson PR, Tredger JM, Williams R. Hepatotoxicity to sodium valproate: a review. Gut 25: 673–681, 1984 Prescott LP, Leslie PJ, Padfield P. Side effects of benoxaprofen. British Medical Journal 284: 1783, 1982 Proctor JD. Hepatitis associated with ranitidine. Journal of the American Medical Association 251: 554, 1984 Puppala AR, Ro JA. Possible association between perliosis and diethylstilbestrol. Postgraduate Medicine 65: 277–281, 1979 Quismorio FP, Bjarnason DF, Kiely WF, Dubois EL, Friou GJ. Antinuclear antibodies in chronic psychotic patients treated with chlorpromazine. American Journal of Psychiatry 132: 1204–1206, 1975 Rager R, Finegold M. Cholestasis in immature newborn infants: is parenteral alimentation responsible? Journal of Pediatrics 86: 264–269, 1975 Rahmat J, Gelfand RL, Gelfand MC, et al. Captopril-associated cholestatic jaundice. Annals of Internal Medicine 101: 56–58, 1985 Ransohoff DF, Jacobs G. Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim. Gastroenterology 80: 816–819, 1981 Read AE, Harrison CV, Sherlock S. Chronic chlorpromazine jaundice with particular reference to its relationship to primary biliary cirrhosis. American Journal of Medicine 31: 249–258, 1961 Rehnqvist N. Intrahepatic jaundice due to warfarin therapy. Acta Medica Scandinavica 204: 335–336, 1978 Reichen J, Simon FRL. Cholestasis. In Arias et al. (Eds.) The liven biology and pathobiology, pp. 785–800, Raven Press, New York, 1982 Reichen J, Simon FRL. Mechanisms of cholestasis. International Review of Experimental Pathology 26: 231–274, 1984 Rene E, Danzinger RG, Hoffman AF. Somatostatin (S) inhibition of bile flow: enhanced ductular reabsorption as the major mechanism of anticholeresis in dogs. Gastroenterology 82: 1240, 1982 Reuben A. Bile formation: sites and mechanisms. Hepatology 4: 15s-24s, 1984 Rex D, Lumeng L, Eble J, et al. Intrahepatic cholestasis and sicca complex after thiabendazole: report of a case and a review of the literature. Gastroenterology 85: 718–721, 1983 Reyes H. The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. Hepatology 2: 87–96, 1982 Reynolds R, Lloyd DA, Singer RP. Cholestatic jaundice induced by flurazepam hydrochloride. Canadian Medical Association Journal 124: 893, 1981 Robeneck H, Rassat J, Temann H. A quantitative freeze-fracture analysis of the gap and tight junctions in the normal and cholestatic human liver. Virchows Archiv B. Cellular Pathology 38: 39–56, 1981 Roberts RJ, Plaa GL. Potentiation and inhibition of L-naphthylisothiocyanate-induced hyperbilirubinemia and cholestasis. Journal of Pharmacology & Experimental Therapeutics 150: 499–506, 1965 Rodriguez-Noriega A, Gomez-Reino J, Lopez-Encuentra A, et al. Toxic epidemic syndrome, Spain 1981: description of a new systemic disease. Lancet 2: 697–702, 1982 Rotmensch HH, Leiser A, Dan M, et al. Evaluation of prajmalium-induced cholestasis by immunologic tests. Archives of Internal Medicine 141: 1797–1801, 1981 Rumore A. Chlorpromazine (‘Largactil’) sensitivity simulating the ‘acute abdomen’. Medical Journal of Australia 2: 752–754, 1962 Sabesin SM, Ragland JB, Freeman MR. Lipoprotein disturbances in liver disease. In Popper & Schaffner (Eds) Progress in liver diseases, Vol. 6, pp. 243–262, Grune & Stratton, New York, 1979 Schachter D. Fluidity and function of hepatocyte plasma membranes. Hepatology 4: 140–151, 1984 Schaffner F, Popper H. Classification and mechanism of cholestasis, pp. 359–386. In Wright et al. (Eds). Liver and biliary disease pathophysiology: diagnosis management, 2nd ed., WB Saunders, Philadelphia, 1985 Schaffner F, Popper H, Perez V. Changes in bile canaliculi produced by norethandrolone: electron microscopic study of human and rat liver. Journal of Laboratory and Clinical Medicine 56: 623–628, 1960 Schapira D, Nahir M, Scharf Y, et al. Cholestatic jaundice induced by gold salt treatment: clinical and immunological aspects — report of one case and review of the literature. Journal of Rheumatology 11: 843–845, 1984 Scharschmidt BF. Bile formation and cholestasis, metabolism and enterohepatic circulation of bile acids and gallstone formation. In Zakim & Boyer (Eds) Hepatology, pp. 927–951, WB Saunders Company, Philadelphia, 1982 Scharschmidt BF & Schmid R. The micellar sink. A quantitative assessment of the association of organic ions with mixed micelles and with macromolecular aggregates in rat bile. Journal of Clinical Investigation 62: 1122–1131, 1978 Scharschmidt BF, Van Dyke RW. Mechanisms of hepatic electrolyte transport. Gastroenterology 85: 1199, 1983 Schenker S, Olson KN, Dunn D, et al. Intrahepatic cholestasis due to therapy of rheumatoid arthritis. Gastroenterology 64: 622–629, 1973 Scheuer PJ, Summerfield JA, Lal S, et al. Rifampicin hepatitis: a clinical and histological study. Lancet 1: 421–425, 1974 Schreiber AH, Simon FR. Estrogen-induced cholestasis: clues to pathogenesis and treatment. Hepatology 3: 607–613, 1983 Seiffert UB, Siede WH. Alkaline phosphatase isoenzymes in serum of rats during cholestasis. Research Experimental Medicine 179: 269–274, 1981 Seki K, Minami Y, Nishikawa M, et al. Non-alcoholic steatohepatitis induced by massive dose estrogen therapy. Gastroenterologica Japonica 18: 197–203, 1983 Selye H. On the toxicity of estrogens with special reference to diethylstilbestrol. Canadian Medical Association Journal 41: 48–49, 1939 Sharp JR, Ishak KG, Zimmerman HJ. Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Annals of Internal Medicine 92: 14–19, 1980 Shay H, Siplet H. Relationship of chemical structure of chlorpromazine to its liver-sensitizing action. Gastroenterology 35: 16–24, 1958 Sheldon GF, Petersen SR, Sanders R. Hepatic dysfunction during hyperalimentation. Archives of Surgery 113: 504–508, 1978 Sheth KJ, Casper JT, Good TA. Interstitial nephritis due to phenytoin hypersensitivity. Journal of Pediatrics 91: 438–441, 1977 Simon FR, Gonzalez M, Sutherland E, et al. Reversal of ethinyl estradiol-induced bile secretory failure with Triton WR-1339. Journal of Clinical Investigation 65: 851–860, 1980 Simon JB, Poon RWM. Lipoprotein-X levels in extrahepatic versus intrahepatic cholestasis. Gastroenterology 75: 177–180, 1978 Slater TF, Eakins MN. Biochemical studies on bile secretion. In Taylor (Ed.) The hepatic biliary system: fundamental and pathological mechanism, pp. 61–80, Plenum Press, New York, 1975 Solis-Herruzo JA, Castellano G, Colina F, et al. Hepatic injury in the toxic epidemic syndrome caused by ingestion of adulterated cooking oil (Spain 1981). Hepatology 4: 131–139, 1984 Souza-Lima MA. Hepatitis associated with ranitidine. Annals of Internal Medicine 101: 207–208, 1984 Sparberg M, Simon N, Del Greco F. Intrahepatic cholestasis due to azathioprine. Gastroenterology 57: 439–441, 1969 Spechler SJ, Sperber I, Doos WG, et al. Cholestasis and toxic epidermal necrolysis associated with phenytoin sodium ingestion: the role of bile duct injury. Annals of Internal Medicine 95: 455–456, 1981 Spellberg MA. Intrahepatic cholestasis vs. posthepatic jaundice: methods of diagnosis with a note on hypercholesterolemia xanthomatosis in a patient with chlorpromazine jaundice. Medical Clinics of North America 48: 53–65, 1964 Sperber I. Secretion or organic anions in the formation of urine and bile. Pharmacology Review 11: 109–134, 1959 Spivak W, Grand RJ. General configuration of cholestasis in the newborn. Journal of Pediatric Gastroenterology and Nutrition 2: 381–392, 1983 Stacher G. Intrahepatische cholestase nach einer nochdosierte Kombination therapie mit Diazepam und Barbituran bei Tetanus-Putienten. Wiener Klinische Wochenschrift 27: 401, 1973 Stagboom G, Loelinger EA. Coumarin-associated hepatitis: a report of two cases. Archives of Internal Medicine 140: 1028–1029, 1980 Stein SI. Possible EES-Induced hepatotoxic reaction. Drug Intelligence & Clinical Pharmacy 13: 612, 1979 Stoll BA, Andrews JT, Motteram R. Liver damage from oral contraceptives. British Medical Journal 1: 960–961, 1966 Stolzer BL, Miller G, White WA, et al. Post-arsenical obstructive jaundice complicated by xanthomatosis and diabetes mellitus. American Journal of Medicine 9: 124–132, 1950 Stramentinoli G, Di Padova C, Gualano M, et al. Ethinylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosyl-L-methionine and its implication in estrogen metabolism. Gastroenterology 80: 154–158, 1981 Stricker BH. Hepatic injury by drugs and environmental agents. In Arias et al. (Eds) The liver annual, Vol. 5, pp. 449–479, Elsevier, Amsterdam, 1986 Stricker BH, Spoelstra P. Drug induced hepatic injury, Elsevier, Amsterdam, 1985 Svanborg A. A study of recurrent jaundice in pregnancy. Acta Obstetrica et Gynecologica Scandinavica 33: 434–444, 1954 Svanborg A, Ohlsson S. Recurrent jaundice of pregnancy: a clinical study of twenty-two cases. American Journal of Medicine 27: 40–59, 1959 Tabuenca JM. Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet 2: 567–568, 1981 Taggart HMA, Alderdice JM. Fatal cholestatic jaundice in elderly patients taking benoxaprofen. British Medical Journal 284: 1372, 1982 Tavoloni N, Boyer JL. Relationship between hepatic metabolism of chlorpromazine and cholestatic effects in the isolated perfused rat liver. Journal of Pharmacology and Experimental Therapeutics 214: 269–274, 1980 Tedesco FJ, Mills LR. Diazepam (Valium) hepatitis. Digestive Diseases & Science 27: 470–472, 1982 Thies PW, Dull WL. Trimethoprim-sulfamethoxazole-induced cholestatic hepatitis. Archives of Internal Medicine 144: 1691–1692, 1984 Thorling L. Jaundice in pregnancy: a clinical study. Acta Medica Scandinavica 151 (Suppl. 302): 1–123, 1955 Ticktin HE, Zimmerman HJ. Hepatic dysfunction and jaundice in patients receiving triacetyloleandomycin. New England Journal of Medicine 267: 964–968, 1962 Tolman KF, Sannella JJ, Freston JW. Chemical structure of erythromycin and hepatotoxicity. Annals of Internal Medicine 81: 58–60, 1974 Tuchweber B, Weber A, Roy C, Yousef IM. Mechanisms of experimentally induced intrahepatic cholestasis. Progress in Liver Diseases 8: 161–178, 1986 Underwood JCE, Shahapi RT, Blackburn EK. Jaundice after treatment of leukaemia with busulphan. British Medical Journal 1: 556–557, 1971 Ungar H, Moran E, Eisner M, et al. Rat intrahepatic biliary tract lesions from alpha-naphthylisothiocyanate. Archives of Pathology 73: 427–435, 1962 Utili R, Abernathy CO, Zimmerman HJ. Cholestatic effects of Escherichia coliendotoxin on the isolated perfused rat liver. Gastroenterology 70: 248–253, 1976 Utili R, Abernathy CO, Aaron SA, et al. In vivoeffects of-Escherichia coliendotoxin on sulfobromophthalein clearance in the guinea pig. Experientia 33: 1631–1632, 1977a Utili R, Abernathy CO, Zimmerman HJ. Studies on the effect of E coliendotoxin on canalicular bile formation in the isolated perfused rat liver. Journal of Laboratory and Clinical Medicine 89: 471–482, 1977b Utili R, Abernathy CO, Zimmerman HJ. Inhibition of Na+, K+adenosinetriphosphatase by endotoxin: a possible mechanism for endotoxin-induced cholestasis. Journal of Infectious Diseases 136: 583–587, 1977c Victorino RMM, Silveira JCB, Baptista A, et al. Jaundice associated with naproxen. Postgraduate Medicine Journal 56: 368–370, 1980 Victorino RMM, Maria VA. Modifications of the lymphocyte transformation test in a case of drug-induced cholestatic hepatitis. Diagnostic Immunology 3: 177–181, 1985 Villeneuve JP, Warner HA. Cimetidine hepatitis. Gastroenterology 77: 143–144, 1979 Vileisis RA, Inwood RJ, Hunt CE. Prospective controlled study of parenteral nutrition-association cholestatic jaundice: effect of protein intake. Journal of Pediatrics 96: 893–897, 1980 Vogin EE, Scott W, Boyd J, et al. Effect of probenecid on indocyanine green clearance. Journal of Pharmacology and Experimental Therapeutics 152: 509–515, 1966 Walker CO, Combes B. Biliary cirrhosis induced by chlorpromazine. Gastroenterology 51: 631–640, 1966 Warren NS. Diflunisal-induced cholestatic jaundice. British Medical Journal 2: 736–737, 1978 Watanabe S, Miyairi M, Oshio C, et al. Phalloidin alters bile canalicular contractility in primary monolayer cultures of rat liver. Gastroenterology 85: 246–253, 1983 Werner SC. Clinical syndromes associated with gonadal failure in man. American Journal of Medicine 3: 52, 1947 Werner SP, Hanger FM, Kritzler FA. Jaundice during methyl-testosterone therapy. American Journal of Medicine 8: 325–331, 1950 Wheeler HO, Ramos OL. Determinants of the flow and composition of bile in the unanesthetized dog during constant infusions of sodium taurocholate. Journal of Clinical Investigation 39: 161–170, 1960 Whittaker SJ, Amar JN, Wanless IR, et al. Sulindac hepatoxicity. Gut 23: 875–877, 1982 Whitington PF. Cholestatis associated with parenteral nutrition in infants. Hepatology 5: 693–696, 1985 Williams CN, Malatjalian DA. Severe penicillin-induced cholestasis in a 91 year old woman. Digestive Diseases and Sciences 26: 470–473, 1981 Wist E. Pathological liver function tests due to trimethoprim-sulfamethoxazole. Tidsskrift for den Norske Laegeforening 102: 1080–1081, 1982 Witzleben CL. Physiologic and morphologic natural history of a model of intrahepatic cholestasis (manganese-bilirubin overload). American Journal of Pathology 66: 577–582, 1972 Wood LJ, Mundo F, Searl J, Powell LW. Sulindac hepatoxocity: effects of acute and chronic exposure. Australian and New Zealand Journal of Medicine 15: 397–401, 1985 Yokoo H, Graig RM, Harwood TR, et al. Griseofulvin-induced cholestasis in Swiss albino mice. Gastroenterology 77: 1082–1087, 1979 Zafrani ES, Ishak KG, Rudzki C. Cholestatic and hepatocellular injury associated with erythromycin esters: report of 9 cases. Digestive Diseases & Sciences 24: 385–396, 1979 Zeiger RS, Schatz M, Sperling W, et al. Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma. Journal of Allergy and Clinical Immunology 66: 438–446, 1980 Zelman S. Liver cell necrosis in chlorpromazine jaundice (allergic cholangiolitis). American Journal of Medicine 27: 708–729, 1959 Zimmerman HJ. Manifestations of hepatotoxicity. Annals of the New York Academy of Science 104: 954–987, 1963 Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver, Appleton-Century-Crofts, New York, 1978 Zimmerman HJ. Intrahepatic cholestasis. Archives of Internal Medicine 139: 1038–1045, 1979 Zimmerman HJ. Chemical hepatic injury and its detection. In Plaa & Hewitt (Eds) Toxicology of the liver, pp. 1–45, Raven Press, New York, 1982 Zimmerman HJ. Intrahepatic cholestasis associated with benoxaprofen therapy: clinical aspects. In Ishak (Ed.) Hepatopathology, pp. 225–229, 36th annual post-graduate course of the American Association for the Study of Liver Disease November 3–4, 1985 Zimmerman HJ. Hepatotoxic effects of oncotherapeutic agents. Progress in Liver Disease 8: 621–642, 1986 Zimmerman HJ, Abernathy CO. Employment of in vitromodels for study of drug toxicity: application to phenothiazine related compounds and erythromycins. In Brunner & Thaler (Eds.) Hepatology: a festschrift for Hans Popper, Raven Press, New York, 1985 Zimmerman HJ, Abernathy CO, Lukacs L, et al. Effects of ticrynafen on hepatic excretory function in the isolated perfused rat liver. Hepatology 2: 255–257, 1982 Zimmerman HJ, Abernathy CO, Utili R. Endotoxin action on bile formation. In Keppler et al. (Eds) Mechanisms of hepatocyte injury and death, pp. 243–264, M.T. Press, Lancaster, 1984 Zimmerman HJ, Ishak KG. Hepatic injury due to drugs and toxins. In MacSween et al. (Eds) Pathology of the liver, pp. 334–386, Churchill Livingstone, London, 1979 Zimmerman HJ, Kendler J. Relationship between structure of phenothiazines and in vitrocytotoxicity. Proceedings of the Society of Experimental Medicine and Biology 135: 201–205, 1970 Zimmerman HJ, Lewis JH. Hepatic toxicity of antimicrobial agents. In Root & Sande (Eds) New dimensions in antimicrobial therapy, pp. 153–201, Churchill Livingstone Inc., New York, 1984 Zimmerman HJ, Lewis JH, Ishak KG, Maddrey WC. Ticrynafen-associated hepatic injury: analysis of 340 cases. Hepatology 4: 315–323, 1984 Zimran A, Abraham AS, Hersch KO. Reversible cholestatic jaundice and hyperamylassaemia associated with captopril treatment. British Medical Journal 287: 1676, 1983 Zuchner H. Cholestatische Hepatose unter Cimetidine. Deutsche Medizinische Wochenschrift 102: 1788–1789, 1977